Latest in Pulmonary News

Latest in Pulmonary News2019-02-15T07:28:32-05:00

Thirty-Day Hospital Readmission Metric Linked to Increased Mortality for HF and Pneumonia

Physicians are at increased pressure to reduce readmissions for certain chronic diseases. A recent study found that implementation of the 30-day readmission rules has been associated with increased 30-day post-discharge mortality for those hospitalized for heart failure and pneumonia.

Post-discharge deaths have increased by 0.25% for patients hospitalized with heart failure and by 0.40% for patients with pneumonia since the implementation of the 30-day readmission rules.
There are approximately 8 million hospitalizations during the study period. Such small increases may account for a large number of deaths.

The findings, published online in JAMA, come from a retrospective cohort study that compared mortality rates among 8.3 million Medicare beneficiaries hospitalized for these common conditions before and after implementation of the Hospital Readmissions Reduction Program (HRRP). This early data should lead physicians to exercise caution in discharging patients prematurely.

Source: Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. JAMA. 2018;320(24):2542-2552. doi:10.1001/jama.2018.19232

Add Corticosteroids to Your Arsenal for the treatment of Inpatient Community-Acquired Pneumonia.

Corticosteroids were both beneficial and cost-effective for hospitalized adults with severe CAP. Hospitalized people with non-severe CAP may also benefit from corticosteroid therapy, but with no survival advantage

In 2015, results of two randomized trials showed that systemic corticosteroids were beneficial for some hospitalized patients with community-acquired pneumonia (CAP; NEJM JW Gen Med Mar 15 2015 and JAMA 2015; 313:677; NEJM JW Gen Med Mar 1 2015 and Lancet 2015; 385:1511). Now, two new meta-analyses — one by the Cochrane Library, and one by the Infectious Diseases Society of America (IDSA) — address whether CAP patients should receive systemic corticosteroids routinely.

These meta-analyses suggest that low-dose (≈40 mg), short-course (3–7 days) systemic corticosteroids should be strongly considered for hospitalized adults with severe CAP. These results do not apply to outpatients with CAP or to inpatients with hospital-acquired pneumonia or ventilator-associated pneumonia. Several ongoing randomized trials probably will clarify steroid use further for pneumonia indications.

Source:
The Cost-effectiveness of Corticosteroids for the treatment of Community-Acquired Pneumonia
Chest. 2018 Nov 15. pii: S0012-3692(18)32727-2. doi: 10.1016/j.chest.2018.11.001.
https://www.ncbi.nlm.nih.gov/pubmed/30448195?dopt=Abstract

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality?

Long-term oxygen therapy (LTOT) is given to improve survival time in people with COPD and severe chronic hypoxemia at rest. The efficacy of oxygen therapy for breathlessness and health-related quality of life (HRQOL) in people with COPD and mild or no hypoxemia who do not meet the criteria for LTOT has not been established. Scientific evidence for its benefits of LTOT dates back to the 1980s when two randomized controlled trials showed prolonged survival in COPD-patients undergoing LTOT for at least 15 hours/day. In contrast, the potential benefits of LTOT in non-COPD-patients has not been well researched and the recommendations for its application are primarily extrapolated from trials on COPD-patients.

Recent Cochrane analysis found that oxygen can relieve breathlessness when given during exercise to mildly hypoxaemic and non-hypoxaemic people with chronic obstructive pulmonary disease who would not otherwise qualify for home oxygen therapy. Findings show that COPD patients without severe hypoxemia undergoing oxygen therapy during exercise training over time do not achieve better exercise capacity or health-related quality of life compared with placebo.

However, LTOT has a beneficial effect on quality of life, dyspnea, and exercise capacity in patients with COPD and exertional hypoxemia.

Source:
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006429.pub3/full

J Bras Pneumol. 2018 Sep-Oct;44(5):390-397. doi: 10.1590/S1806-37562017000000019.
Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year.
https://www.ncbi.nlm.nih.gov/pubmed/30517340

Latest in Pulmonary Research

  1. Zhang, YW, Tao, R, Wu, D, Ou, JC, Kong, ZC, Zhu, ZZ et al.. Research progress on the association between lung cancer and pulmonary embolism. J Cardiothorac Surg. 2025;20 (1):2. doi: 10.1186/s13019-024-03321-6. PubMed PMID:39754212 .
  2. Tomazini, BM, Besen, BAMP, Santos, RHN, Nassar, AP Jr, Veiga, TS, Campos, VB et al.. Clinical impact of healthcare-associated infections in Brazilian ICUs: a multicenter prospective cohort. Crit Care. 2025;29 (1):4. doi: 10.1186/s13054-024-05203-8. PubMed PMID:39754200 .
  3. Gong, W, Vaishnani, DK, Jin, XC, Zeng, J, Chen, W, Huang, H et al.. Evaluation of an enhanced ResNet-18 classification model for rapid On-site diagnosis in respiratory cytology. BMC Cancer. 2025;25 (1):10. doi: 10.1186/s12885-024-13402-3. PubMed PMID:39754166 .
  4. Zhang, J, Yang, S, Chen, X, Zhang, F, Guo, S, Wu, C et al.. Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway. Chin Med. 2025;20 (1):2. doi: 10.1186/s13020-024-01054-1. PubMed PMID:39754146 .
  5. Zhu, L, Liu, J, Huang, X, Hu, J. Preoperative immunochemotherapy versus chemotherapy as first-line treatment for patients with stage I-IIIB small-cell lung cancer. BMC Cancer. 2025;25 (1):8. doi: 10.1186/s12885-024-13405-0. PubMed PMID:39754112 .
  6. Li, W, Min, A, Zhao, W, Li, W, Li, S, Ran, S et al.. Predictors and prognosis of elderly hip fracture patients with perioperative atrial fibrillation: a nested case-control study. BMC Geriatr. 2025;25 (1):4. doi: 10.1186/s12877-024-05647-1. PubMed PMID:39754053 .
  7. Li, L, Liang, J, Zhang, H, Guo, J, Li, S, Li, M et al.. Emergence and clinical challenges of ST11-K64 carbapenem-resistant Klebsiella pneumoniae: molecular insights and implications for antimicrobial resistance and virulence in Southwest China. BMC Infect Dis. 2025;25 (1):19. doi: 10.1186/s12879-024-10390-4. PubMed PMID:39754049 .
  8. Zhang, Y, Su, C, Zhang, Y, Ding, S, Yan, X, Zhang, J et al.. Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study. BMC Infect Dis. 2025;25 (1):18. doi: 10.1186/s12879-024-10370-8. PubMed PMID:39754040 .
  9. Wei, Y, Sun, MM, Zhang, RL, Wang, L, Yang, LH, Shan, CL et al.. Discovery of novel dual-target inhibitors of LSD1/EGFR for non-small cell lung cancer therapy. Acta Pharmacol Sin. 2025; :. doi: 10.1038/s41401-024-01439-w. PubMed PMID:39753983 .
  10. Zhou, SC, Wang, L, Chen, X, Xiao, HQ, Yu, F, Tian, J et al.. Enhancing bibliometric methods in simulation-based robotic surgery training. J Robot Surg. 2025;19 (1):40. doi: 10.1007/s11701-024-02207-y. PubMed PMID:39753937 .
  11. Jasim, SA, Farhan, SH, Ahmad, I, Hjazi, A, Kumar, A, Jawad, MA et al.. A cutting-edge investigation of the multifaceted role of SOX family genes in cancer pathogenesis through the modulation of various signaling pathways. Funct Integr Genomics. 2025;25 (1):6. doi: 10.1007/s10142-024-01517-6. PubMed PMID:39753912 .
  12. Shan, N, Shang, Y, He, Y, Wen, Z, Ning, S, Chen, H et al.. Common biomarkers of idiopathic pulmonary fibrosis and systemic sclerosis based on WGCNA and machine learning. Sci Rep. 2025;15 (1):610. doi: 10.1038/s41598-024-84820-3. PubMed PMID:39753882 .
  13. Hong, H, Han, H, Wang, L, Cao, W, Hu, M, Li, J et al.. ABCF1-K430-Lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathway. Cell Death Differ. 2025; :. doi: 10.1038/s41418-024-01436-w. PubMed PMID:39753865 .
  14. Wang, M, Li, Y, Lei, J, Jiang, H. Viral nucleic acid load in the milk of lactating mothers with COVID-19 and the prognosis of infants. Sci Rep. 2025;15 (1):709. doi: 10.1038/s41598-024-84838-7. PubMed PMID:39753837 .
  15. Köksoy, AY, Şimşek, Y, Epçaçan, S, Bayrakci, US. Ambulatory blood pressure profiles of children with asthma compared to healthy controls. Pediatr Nephrol. 2025; :. doi: 10.1007/s00467-024-06615-y. PubMed PMID:39753687 .
  16. Shosha, MI, El-Ablack, FZ, Saad, EA. New thiazole derivative as a potential anticancer and topoisomerase II inhibitor. Sci Rep. 2025;15 (1):710. doi: 10.1038/s41598-024-81294-1. PubMed PMID:39753588 .
  17. Fernández González, AM, Moreira Lorenzo, N, Cantador Huertos, B, Causse Del Río, M, González García, FJ, Álvarez Kindelan, A et al.. Mucormycosis Infection in Lung Transplant Patients: Experience in Andalusia, Spain. Transplant Proc. 2025; :. doi: 10.1016/j.transproceed.2024.11.030. PubMed PMID:39753494 .
  18. Leedman, N, Lee, YCG, Houghton, D, Green, C. A case of corticosteroid-responsive organising pneumonia in a patient with pulmonary transthyretin amyloidosis (ATTR). Pathology. 2024; :. doi: 10.1016/j.pathol.2024.09.016. PubMed PMID:39753488 .
  19. Marks, JA, Ahn, J, Reuss, JE, Barbie, D, Altan, M, Gutierrez, ME et al.. Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma. Clin Lung Cancer. 2024; :. doi: 10.1016/j.cllc.2024.12.001. PubMed PMID:39753485 .
  20. Rosner, GM, Goswami, HB, Sessions, K, Mendyka, LK, Kerin, B, Vlasac, I et al.. Lung-kidney axis in cystic fibrosis: Early urinary markers of kidney injury correlate with neutrophil activation and worse lung function. J Cyst Fibros. 2025; :. doi: 10.1016/j.jcf.2024.12.007. PubMed PMID:39753455 .
  21. Richards, ND, Howell, SJ, Bellamy, MC, Beck, J. The diverse effects of ketamine, a jack-of-all-trades: a narrative review. Br J Anaesth. 2025; :. doi: 10.1016/j.bja.2024.11.018. PubMed PMID:39753406 .
  22. Huo, B, Kontouli, KM, Manos, D, Xu, Z, Chun, S, Fris, J et al.. Screening Criteria Evaluation for Expansion in Pulmonary Neoplasias (SCREEN) II. Can J Surg. 2025;68 (1):E1-E9. doi: 10.1503/cjs.015223. PubMed PMID:39753323 .
  23. Guo, D, Huang, K, Guan, X, Ding, R, Zhu, D, Zhao, Y et al.. Association between chronic respiratory diseases and frailty in Chinese elderly: a population-based longitudinal study. BMJ Open Respir Res. 2025;12 (1):. doi: 10.1136/bmjresp-2023-002171. PubMed PMID:39753242 .
  24. Navas Nazario, AA, Ulysse, S, Craver, EC, Patel, TR. Social Determinants' Role in Pediatric Respiratory Health: Health Insights from Central Florida. South Med J. 2025;118 (1):31-38. doi: 10.14423/SMJ.0000000000001772. PubMed PMID:39753234 .
  25. Song, Q, Sui, J, Yang, Y, Zhang, H, Ya, L, Yang, L et al.. Fructose-1,6-bisphosphatase 1 in cancer: Dual roles, mechanistic insights, and therapeutic potential - A comprehensive review. Int J Biol Macromol. 2025; :139273. doi: 10.1016/j.ijbiomac.2024.139273. PubMed PMID:39753180 .
Search PubMed

Search Terms: Asthma, COPD, Lung Cancer, Pneumonia, Pulmonary Fibrosis

Copyright © 2016 Allergy Sleep & Lung Care. All Rights Reserved.
This website does not contain medical advice and the use of this website does not create a physician/patient relationship between you and Allergy Sleep & Lung Care.
Terms of Use | HIPAA Privacy Policy | Sitemap | Privacy Policy

Go to Top